E

Elliquence

Manufactures minimally invasive neurosurgery devices

Controller

Full-TimePosted on 10/27/2026
$180k - $200k/yr
Senior, Expert
Bachelor's, MBA
Woodbury, NY, USA
In PersonOn-site in Woodbury, NY.
AccountingFinancial Accounting

About the job

Requirements
  • A bachelor's degree in Accounting, Finance, or a related field is required.
  • Completion of the CPA is required, including at least 3 years of experience in public accounting audit; experience at a national or regional firm is preferred.
  • Eight to ten years of progressive accounting and financial operations experience is required.
  • At least five years owning core accounting functions, including leading a team of direct reports, budgeting, forecasting, financial reporting, audits, reconciliations, tax compliance, regulations, and financial controls is required.
  • Medical device industry experience in the finance or accounting function is required.
  • Experience developing accounting and finance infrastructure in a high-growth company is a plus.
  • Hands-on ERP experience is required; Macola experience is strongly preferred.
  • Advanced Microsoft Excel skills and strong analytical abilities are required.
  • Strong technical accounting skills and a record of improving accuracy, efficiency, and operational precision are required.
  • Organizational and problem-solving skills, attention to detail, and the ability to balance precision with speed are required.
  • Clear written and verbal communication skills and the ability to partner effectively across financial and non-financial stakeholders are required.
Responsibilities
  • Lead accounting operations, financial reporting, budgeting, financial compliance, and internal controls.
  • Manage general ledger, accounts payable, accounts receivable, inventory accounting, revenue recognition, and related accounting activities.
  • Manage monthly, quarterly, and annual close processes and ensure timely, accurate financial statements.
  • Lead the team to ensure entries, reconciliations, accruals, and supporting schedules are accurate and timely.
  • Manage preparation of financial reports, management dashboards, key performance indicators, and variance analyses for executive leadership.
  • Maintain effective internal controls, accounting policies, and procedures.
  • Establish and maintain accounting policies and procedures in accordance with generally accepted accounting principles, including appropriate treatment of complex or significant transactions.
  • Coordinate external and internal financial audits, bank field audits, and other regulatory examinations with the team and cross-functional leadership.
  • Serve as the primary Finance point of contact for auditors, tax advisors, and external accounting partners.
  • Oversee required tax filings and compliance reporting.
  • Direct the annual budgeting process and lead financial forecasting and long-range planning.
  • Monitor actual results against budget, investigate variances, and provide recommendations.
  • Partner with leadership to support financial planning and operational decision-making.
  • Supervise, develop, and support accounting team members while ensuring accountability and timely completion of responsibilities.
  • Identify opportunities to streamline processes, reduce manual work, improve reporting accuracy, and strengthen internal controls.
  • Provide financial and accounting insights to help leaders understand performance, manage spending, and improve financial accountability.
  • Ensure spending decisions are disciplined and aligned with company priorities.
  • Oversee the ERP system enterprise-wide, including implementation and system improvements.
  • Develop reporting tools for forecasting and budgeting.
Desired Qualifications
  • An MBA is preferred.
  • Experience at a national or regional public accounting firm is preferred.
  • Experience developing accounting and finance infrastructure in a high-growth company is a plus.
  • Macola experience is strongly preferred.

About the company

Elliquence develops and manufactures medical devices for minimally invasive surgery, focusing on neurosurgery, endoscopic spine, orthopedic, and pain management. Its core technology is the Surgi-Max energy source that delivers 4.0 MHz radiowave energy for precise cutting, coagulation, and tissue ablation at low temperatures to minimize damage to surrounding tissue. The product lineup includes capital equipment like Surgi-Max Plus, procedure-specific systems such as Disc-FX and Trigger-Flex, and a range of endoscopes, drills, and ultrasonic bone-cutting tools, sold with disposable instruments and training services. The company differentiates itself through a heritage linked to Irving Ellman, its end-to-end offering, and its emphasis on education to promote adoption, with the goal of improving patient outcomes and expanding global use of minimally invasive spine, neurosurgical, and pain management techniques.

Company Size

51-200

Company Stage

N/A

Total Funding

N/A

Headquarters

Hempstead, New York

Founded

2008

Get referred to Elliquence

See people who can refer or advise you

Simplify Jobs

Simplify's Take

What believers are saying

  • March 5, 2025 co-CEOs Anthony Carone and Anastasia Chen refreshed execution.
  • ISASS 2026 in Miami spotlights ongoing surgeon engagement around endoscopic spine.
  • 2026 openings in Baldwin, El Segundo, and Boca Raton signal active hiring.

What critics are saying

  • Shanghai Kinetic's 2018 ownership lets a parent divert strategy, capital, or distribution.
  • Leadership shifted in March 2025, creating execution risk during a commercial reset.
  • If Kinetic reallocates spend, Elliquence becomes a captive brand with shrinking autonomy.

What makes Elliquence unique

  • Surgi-Max’s 4.0 MHz low-temperature radiowave platform preserves tissue during spine procedures.
  • Disc-FX and Trigger-Flex anchor a procedure-specific spine portfolio with disposable revenue.
  • EndoSpine Academy 2026 and surgeon training deepen adoption beyond device sales.

Help us improve and share your feedback! Did you find this helpful?

Benefits

  • Flexible Work Hours

Company News

PR Newswire
Oct 8th, 2026
elliquence names spine industry veteran Bill Pfost Chief Executive Officer.

elliquence names spine industry veteran Bill Pfost Chief Executive Officer. Elliquence Oct 08, 2026, 09:00 ET Appointment of Bill Pfost brings more than three decades of spine industry experience to support the company's continued growth and broader adoption of minimally invasive endoscopic spine solutions. BALDWIN, N.Y., Oct. 8, 2026 /PRNewswire-PRWeb/ - elliquence, LLC, a global leader in minimally invasive surgical technologies, today announced the appointment of Bill Pfost as Chief Executive Officer. A seasoned medical device executive with more than 30 years of experience in the spine industry, he will lead elliquence as the company continues to expand its presence in the U.S. and global markets and advance the adoption of minimally invasive endoscopic approaches to spine care. Pfost brings extensive commercial and executive leadership experience to elliquence, with a career spanning the development, commercialization and distribution of some of the spine industry's most recognized technologies. Most recently, he served as Chief Revenue Officer of Companion Spine, driving the company's vision as a leader in posterior dynamic stabilization. His previous leadership roles include executive positions at Zimmer Spine, Paradigm Spine, and American Medical Concepts. "Bill brings a rare combination of deep spine industry experience, commercial leadership and an understanding of how innovative technologies gain acceptance among physicians and patients," said Daniel Hui, member of the elliquence Board of Directors. "As elliquence works to broaden awareness and adoption of endoscopic approaches to spine care, his industry knowledge, relationships and perspective on the evolving treatment landscape will be invaluable in guiding the company's next stage of growth." The appointment comes as elliquence continues to build awareness of minimally invasive endoscopic techniques as an important option across a range of spine conditions and procedures. By enabling physicians to access and treat targeted anatomy with minimal disruption to surrounding healthy tissue, endoscopic interventions may offer appropriately selected patients reduced recovery times and the potential for same-day outpatient treatment. This approach reflects elliquence's longstanding philosophy that, when clinically appropriate, less intervention can deliver meaningful benefits for both physicians and patients. "Throughout my career, I've seen how advances in minimally invasive techniques can fundamentally change the way physicians approach patient care," said Pfost. "I believe that elliquence is well-positioned to evolve as a leader in the advancement of endoscopic procedures. elliquence has spent decades developing the technologies, clinical relationships and expertise to help advance this approach, and I'm excited to build on that foundation, broaden its adoption and lead the company into its next phase of growth." Pfost began his career at U.S. Surgical Corporation, where he played a role in driving adoption of laparoscopic cholecystectomy as minimally invasive surgical techniques were transforming general surgery. Over the ensuing three decades, he has held senior sales, marketing and executive leadership positions across the medical device and spine industries and has been involved in the development and distribution of less invasive and interventional technologies. As CEO, Pfost will provide strategic leadership across elliquence's operations, commercial organization and continued market development, with an emphasis on expanding the understanding of endoscopic spine procedures among physicians and patients and supporting the company's long-term growth. About elliquence elliquence, LLC is a leading medical device company based in New York, specializing in advanced minimally invasive surgical technologies. With over 50 years of innovation, elliquence is recognized globally for its Surgi-Max Ultra radiofrequency platform alongside its Trigger-Flex bipolar systems, which provides surgeons with unparalleled precision in soft tissue management and preservation. The company's mission is to partner with the medical community to develop high-quality, cost-effective solutions that enhance patient outcomes while reducing procedural risks and recovery times. elliquence's cutting-edge technologies are widely used in endoscopic spine surgery, orthopedics, neurosurgery, and pain management. Known for pushing the boundaries of surgical innovation, elliquence continues to lead the charge in improving the efficiency and effectiveness of minimally invasive procedures. Media Contact Scott Truelson, Elliquence, 1 516.277.9016, [email protected], Elliquence.com SOURCE Elliquence